Educational information, not medical advice — ask your doctor or midwife.
Chandraprabha Vati is one of Ayurveda's most revered classical formulations, documented in ancient texts including the Ashtanga Hridayam and Sharangdhara Samhita. Its name translates to 'moonlight tablet,' reflecting the traditional belief that it brings clarity and brightness to the body's systems. It combines 37 herbs, minerals, and plant resins — each selected for a specific therapeutic role — making it one of the most complex multi-ingredient formulas in the Ayurvedic tradition.
The formula works across several body systems simultaneously. Shilajit and Guggul provide the core bioactive backbone, supporting energy metabolism and reducing inflammation in the urinary and reproductive tracts. Trikatu (the three-pepper blend) enhances absorption of the other ingredients, while Triphala supports digestion and gentle detoxification. Haridra (turmeric) and Amalaki add antioxidant and immune-supporting properties throughout.
Chandraprabha Vati is almost universally available as pressed tablets or traditional vati (pills) ranging from 250–500 mg each. Some manufacturers offer a powder form for mixing into warm water or milk. The tablet is the most standardized and convenient format for consistent dosing.
Chandraprabha Vati has been in continuous use in India for over a thousand years, referenced in Ayurvedic classical texts as a cornerstone treatment for mutravaha srotas (the urinary channel) and shukravaha srotas (the reproductive channel). Its multi-herb design reflects the Ayurvedic principle of formulating synergistically rather than relying on a single active compound.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.